CLDXCelldex Therapeutics, Inc.
$29.89+21% 1Y
$29.89
$22.5852 weeks$44.88
Is the price fair?
What CLDX's price assumes
Celldex Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1732× revenue.
1732
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.08
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 1396
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 5.08
- EV / EBIToperating margin −206220%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 1396
- Market capitalisation
- $2.68B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks